Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Dizdarević S[au]:

Molecular radiotheragnostics in prostate cancer. Du Y et al. Clin Med (Lond). (2017)

PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy. Vera JH et al. Eur J Nucl Med Mol Imaging. (2017)

Interventional nuclear medicine. McCready VR et al. Eur J Nucl Med Mol Imaging. (2013)

Search results

Items: 50

1.

Lack of whey acidic protein four disulphide core (WFDC) 2 protease inhibitor causes neonatal death from respiratory failure in mice.

Nakajima K, Ono M, Radović U, Dizdarević S, Tomizawa SI, Kuroha K, Naganatsu G, Hoshi I, Matsunaga R, Shirakawa T, Kurosawa T, Miyazaki Y, Seki M, Suzuki Y, Koseki H, Nakamura M, Suda T, Ohbo K.

Dis Model Mech. 2019 Sep 27. pii: dmm.040139. doi: 10.1242/dmm.040139. [Epub ahead of print]

2.

Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice.

Dizdarevic S, McCready R, Vinjamuri S.

Eur J Nucl Med Mol Imaging. 2019 Aug 30. doi: 10.1007/s00259-019-04475-5. [Epub ahead of print]

PMID:
31471713
3.

The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma.

Dizdarevic S, Tulchinsky M, McCready VR, Mihailovic J, Vinjamuri S, Buscombe JR, Lee ST, Frangos S, Sathekge M, Siraj Q, Choudhury P, Bom H, Franceschi M, Ugrinska A, Paez D, Hussain R, Mailman J, Luster M, Virgolini I; WARMTH Thyroid Group.

World J Nucl Med. 2019 Apr-Jun;18(2):123-126. doi: 10.4103/wjnm.WJNM_117_18. No abstract available.

4.

Bone scan index as metastatic bone disease quantifier and predictor of radium-223-dichloride biochemical response.

Roque V, Jessop M, Pereira L, Gape P, Dizdarevic S, Sousa E, Carolino E.

Nucl Med Commun. 2019 Jun;40(6):588-596. doi: 10.1097/MNM.0000000000001005.

PMID:
30908340
5.

Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice.

Dizdarevic S, Petersen PM, Essler M, Versari A, Bourre JC, la Fougère C, Valdagni R, Paganelli G, Ezziddin S, Kalinovský J, Bayh I, Du Y.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1102-1110. doi: 10.1007/s00259-019-4261-y. Epub 2019 Jan 12.

6.

Nuclear medicine RIP (radiation induced phobia); improving the image.

McCready VR, Dizdarevic S.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2475-2477. doi: 10.1007/s00259-018-4168-z. Epub 2018 Sep 25. No abstract available.

PMID:
30255297
7.

223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice.

Dizdarevic S, Jessop M, Begley P, Main S, Robinson A.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2264-2273. doi: 10.1007/s00259-018-4083-3. Epub 2018 Jul 11.

8.

Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy.

Tulchinsky M, Binse I, Campennì A, Dizdarevic S, Giovanella L, Jong I, Kairemo K, Kim CK.

J Nucl Med. 2018 May;59(5):723-725. doi: 10.2967/jnumed.118.211359. Epub 2018 Apr 13. No abstract available.

9.

Molecular radiotheragnostics in prostate cancer.

Du Y, Dizdarevic S.

Clin Med (Lond). 2017 Oct;17(5):458-461. doi: 10.7861/clinmedicine.17-5-458.

10.

Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.

Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T.

Acta Radiol. 2017 Dec;58(12):1476-1484. doi: 10.1177/0284185117701305. Epub 2017 Apr 6.

PMID:
28382828
11.

PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.

Vera JH, Ridha B, Gilleece Y, Amlani A, Thorburn P, Dizdarevic S.

Eur J Nucl Med Mol Imaging. 2017 May;44(5):895-902. doi: 10.1007/s00259-016-3602-3. Epub 2017 Jan 5. Review.

PMID:
28058461
12.

Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules-the SPUtNIk study.

Qureshi NR, Rintoul RC, Miles KA, George S, Harris S, Madden J, Cozens K, Little LA, Eichhorst K, Jones J, Moate P, McClement C, Pike L, Sinclair D, Wong WL, Shekhdar J, Eaton R, Shah A, Brindle L, Peebles C, Banerjee A, Dizdarevic S, Han S, Poon FW, Groves AM, Kurban L, Frew AJ, Callister ME, Crosbie P, Gleeson FV, Karunasaagarar K, Kankam O, Gilbert FJ.

BMJ Open Respir Res. 2016 Oct 14;3(1):e000156. eCollection 2016.

13.

Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer.

Teagle AR, Gilbert DC, Jones JR, Burkill GJ, McKinna F, Dizdarevic S.

Nucl Med Commun. 2016 Oct;37(10):1038-45. doi: 10.1097/MNM.0000000000000560.

PMID:
27341410
14.

Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT.

Keramida G, Hunter J, Dizdarevic S, Peters AM.

Ann Nucl Med. 2016 Apr;30(3):200-6. doi: 10.1007/s12149-015-1045-8. Epub 2016 Jan 14.

PMID:
26768891
15.

Nuclear medicine training and practice in the UK.

Neilly B, Dizdarevic S, Prvulovich L, Buscombe J, Lewington V.

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):800-3. doi: 10.1007/s00259-015-3255-7. No abstract available.

PMID:
26592940
16.

The appropriate whole-body index on which to base standardized uptake value in 2-deoxy-2-[(18)F]fludeoxyglucose PET.

Keramida G, Hunter J, Dizdarevic S, Peters AM.

Br J Radiol. 2015 Aug;88(1052):20140520. doi: 10.1259/bjr.20140520. Epub 2015 Jun 17.

17.

Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?

Keramida G, Dizdarevic S, Bush J, Peters AM.

Eur Radiol. 2015 Sep;25(9):2701-8. doi: 10.1007/s00330-015-3659-6. Epub 2015 Apr 22.

PMID:
25899414
18.

Early gated SPECT adenosine myocardial perfusion imaging may influence the therapeutic management of patients with coronary artery disease.

Dizdarevic S, Singh N, Nair S, de Belder A, Ryan N, Aplin M, Vara A, James R, McCready VR, Peters AM.

Nucl Med Commun. 2015 Apr;36(4):386-91. doi: 10.1097/MNM.0000000000000258.

PMID:
25569866
19.

Accumulation of (18)F-FDG in the liver in hepatic steatosis.

Keramida G, Potts J, Bush J, Verma S, Dizdarevic S, Peters AM.

AJR Am J Roentgenol. 2014 Sep;203(3):643-8. doi: 10.2214/AJR.13.12147. Erratum in: AJR Am J Roentgenol. 2015 May;204(5):1137.

PMID:
25148170
20.

Old tracer for a new purpose: potential role for 99mTc-2-Methoxyisobutylisonitrile (99mTc-MIBI) in renal transplant care.

Dizdarevic S, Aplin M, Newport MJ, Ryan N, Holt S, Goubet S, Goldberg L, Miles KA, Peters AM.

Nucl Med Commun. 2014 Oct;35(10):1058-66. doi: 10.1097/MNM.0000000000000165.

PMID:
25025147
21.

Hepatic steatosis is associated with increased hepatic FDG uptake.

Keramida G, Potts J, Bush J, Dizdarevic S, Peters AM.

Eur J Radiol. 2014 May;83(5):751-5. doi: 10.1016/j.ejrad.2014.01.027. Epub 2014 Feb 7. Erratum in: AJR Am J Roentgenol. 2015 May;204(5):1137.

PMID:
24581596
22.

Radiolabelled apoptotic probe may be a vehicle for a novel multimodality radionuclide tumour therapy.

Dizdarevic S, McCready R, Turner JF, Bagley MC, Blower P, Schmid P, Flux G, Hall A, Ziv I.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1255-6. doi: 10.1007/s00259-014-2725-7. Epub 2014 Feb 25. No abstract available.

PMID:
24566950
24.

Diet and 18F bone imaging.

McCready VR, Dizdarevic S.

Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1925. doi: 10.1007/s00259-013-2565-x. Epub 2013 Sep 27. No abstract available.

PMID:
24072347
25.

Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules.

Wale A, Miles KA, Young B, Zammit C, Williams A, Quin J, Dizdarevic S.

Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):105-15. doi: 10.1007/s00259-013-2546-0. Epub 2013 Sep 13.

PMID:
24030667
26.

Renal and hepatic kinetics of Tc-99m-labelled hexakis-methoxy-isobutyl Isonitrile.

Dizdarevic S, Aplin M, Ryan N, Holt SG, Goldberg L, Miles KA, Peters AM.

Drug Metab Lett. 2012;6(4):242-6.

PMID:
23745949
27.

Interventional nuclear medicine.

McCready VR, Dizdarevic S, Aplin M.

Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1044-6. doi: 10.1007/s00259-013-2413-z. No abstract available.

PMID:
23640468
28.

Association between bile acid turnover and osteoporosis in postmenopausal women.

Hanly R, Ryan N, Snelling H, Walker-Bone K, Dizdarevic S, Peters AM.

Nucl Med Commun. 2013 Jun;34(6):597-600. doi: 10.1097/MNM.0b013e3283608993.

PMID:
23619342
29.

Necessity for long-term follow-up of patients with head and neck paraganglioma and mutation in the succinate dehydrogenase genes: an index case report and literature review.

Samji KB, Crown AL, Buxton-Thomas MS, Aylwin SJ, Schulte KM, Dizdarevic S.

Endocr Pract. 2012 Sep-Oct;18(5):e130-4. doi: 10.4158/EP11184.CR. Review.

PMID:
22982783
30.

Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival.

Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K.

Eur Radiol. 2012 Apr;22(4):796-802. doi: 10.1007/s00330-011-2319-8. Epub 2011 Nov 17.

PMID:
22086561
31.

Imaging of multidrug resistance in cancer.

Dizdarevic S, Peters AM.

Cancer Imaging. 2011 Mar 1;11:1-8. doi: 10.1102/1470-7330.2011.0001. Review.

32.

Unusual initial manifestation of metastatic follicular carcinoma of the thyroid with thyrotoxicosis diagnosed by technetium Tc 99m pertechnetate scan: case report and review of literature.

Sundaraiya S, Dizdarevic S, Miles K, Quin J, Williams A, Wheatley T, Zammitt C.

Endocr Pract. 2009 Jul-Aug;15(5):458-62. doi: 10.4158/EP08300.CRR. Review.

PMID:
19491082
33.

[Acute coronary syndrome at the Institute of Emergency Medicine in Sarajevo].

Slatina E, Dizdarević S, Musić M.

Lijec Vjesn. 2009;131 Suppl 4:58-61. Croatian.

PMID:
23120874
34.

[Sarcoma Ewing left hemithorax].

Selimović A, Mujicić E, Mesihović-Dinarević S, Saratević E, Dizdarević A, Dizdarević S, Guska S.

Med Arh. 2006;60(6 Suppl 1):54-6. Bosnian.

PMID:
18172983
35.

Re: CT appearances of talc pleurodesis.

Burkill GJ, Miles KA, Dizdarevic S.

Clin Radiol. 2007 Sep;62(9):914-5. Epub 2007 Jul 13. No abstract available.

PMID:
17662743
36.

L-Isoleucyl-L-serine 0.33-hydrate, L-phenylalanyl-L-serine and L-methionyl-L-serine 0.34-hydrate.

Görbitz CH, Bruvoll M, Dizdarevic S, Fimland N, Hafizovic J, Kalfjøs HT, Krivokapic A, Vestli K.

Acta Crystallogr C. 2006 Jan;62(Pt 1):o22-5. Epub 2005 Dec 16.

PMID:
16397334
37.

Reference ranges for 51Cr-EDTA measurements of glomerular filtration rate in children.

Blake GM, Gardiner N, Gnanasegaran G, Dizdarevic S.

Nucl Med Commun. 2005 Nov;26(11):983-7.

PMID:
16208176
38.

[Ultrasound in the diagnosis and differential diagnosis of acute appendicitis in childhood].

Vegar-Zubović S, Lincender L, Dizdarević S, Dalagija F.

Med Arh. 2003;57(4):233-6. Croatian.

PMID:
14528718
39.

[Praziquantel in the prevention of recurrence of human echinococcosis].

Dautović-Krkić S, Huskić J, Cengić D, Dizdarević S, Beslić S, Guska S, Mesihović H, Mulić S.

Med Arh. 2002;56(5-6):263-6. Croatian.

PMID:
12693324
40.

[Neurosarcoidosis presenting with transitory neurodeficit and generalized epileptic seizures associated with migraine].

Dizdarević K, Dizdarević S, Dizdarević Z.

Med Arh. 1998;52(3):159-62. Croatian.

PMID:
9863323
41.

[Percutaneous drainage of abdominal fluid collections guided by computer tomography].

Lincender L, Radnić D, Vrcić D, Dimitrijević K, Dizdarević S.

Med Arh. 1996;50(1-2):31-3. Croatian.

PMID:
9333677
42.

[Our approach to the treatment of burns].

Dizdarević S, Lomas M, Zvizdić Z, Alibegović J.

Med Arh. 1996;50(1-2):27-9. Croatian.

PMID:
9333675
43.

[Correction of hypospadias with a preputial flap--personal experience].

Dizdarević S, Drasković B, Haverić N, Nevjestić Z.

Acta Chir Iugosl. 1991;38(1):97-101. Croatian.

PMID:
8701695
44.

[Injuries of the pelvis associated with injuries to other organs].

Dizdarević S, Lomas M, Nevjestić Z, Kafka D.

Acta Chir Iugosl. 1989;36(1):91-100. Croatian.

PMID:
2711809
45.

[Abdominal injuries in our patients during the past 10 years].

Dizdarević S, Besarević S, Drasković B, Haverić N, Nevjestić Z.

Acta Chir Iugosl. 1989;36 Suppl 2:738-40. Croatian.

PMID:
2618493
46.

[High atresia of the anus and rectum--our approach].

Dizdarević S, Potkonjak M, Besarović S, Drasković B, Haverić N.

Acta Chir Iugosl. 1988;35(2):225-31. Croatian. No abstract available.

PMID:
3213357
47.

[Early reintervention in dehiscence of the anastomosis of the small intestine and colonic perforation at the site of the serous lesion].

Dizdarević S, Haverić N, Nevjestić Z.

Acta Chir Iugosl. 1987;34(1):69-73. Croatian. No abstract available.

PMID:
3505394
48.

[Open and closed injuries of the abdominal organs based on our data].

Dizdarević S.

Acta Chir Iugosl. 1986;33(1):55-60. Croatian. No abstract available.

PMID:
3825425
49.

[Stenoses and atresias of the duodenum].

Dizdarević S, Kafka I, Lopandić M.

Acta Chir Iugosl. 1985;32(1):41-6. Croatian. No abstract available.

PMID:
4050263
50.

[Use of trasylol in the prevention of adhesive ileus in children with a ruptured appendix].

Dizdarevic S, Lopandić M, Potkonjak M, Sosić M, Lomas M, Rafaeli Z.

Med Arh. 1981;35(5-6):287-8. Croatian. No abstract available.

PMID:
6178908

Supplemental Content

Loading ...
Support Center